There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Assertio Therapeutics (ASRT – Research Report), Longboard Pharmaceuticals (LBPH – Research Report) and Travere Therapeutics (TVTX – Research Report) with bullish sentiments.
Assertio Therapeutics (ASRT)
Lake Street analyst Thomas Flaten maintained a Buy rating on Assertio Therapeutics today and set a price target of $3.00. The company’s shares closed last Monday at $1.22, close to its 52-week low of $0.73.
According to TipRanks.com, Flaten has 0 stars on 0-5 stars ranking scale with an average return of
Currently, the analyst consensus on Assertio Therapeutics is a Moderate Buy with an average price target of $3.00.
See the top stocks recommended by analysts >>
Longboard Pharmaceuticals (LBPH)
H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on Longboard Pharmaceuticals today and set a price target of $60.00. The company’s shares closed last Monday at $20.60.
According to TipRanks.com, Trucchio ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
Longboard Pharmaceuticals has an analyst consensus of Strong Buy, with a price target consensus of $42.50, representing a 97.2% upside. In a report issued on April 30, Robert W. Baird also initiated coverage with a Buy rating on the stock with a $36.00 price target.
Travere Therapeutics (TVTX)
In a report released today, Laura Chico from Wedbush maintained a Buy rating on Travere Therapeutics, with a price target of $13.00. The company’s shares closed last Monday at $6.55, close to its 52-week low of $5.12.
According to TipRanks.com, Chico is a 3-star analyst with an average return of
Travere Therapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $14.20, implying a 126.5% upside from current levels. In a report issued on April 24, H.C. Wainwright also maintained a Buy rating on the stock with a $19.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ASRT:
- ASRT Earnings this Week: How Will it Perform?
- Assertio Holdings, Inc. to Report First Quarter 2024 Financial Results on May 6, 2024
- Assertio Holdings appoints Sig Kirk to board of directors
- Assertio Holdings Chairman Declines Reelection Amid Disputes
- Assertio to Present at LD Micro Invitational Conference in New York City
